The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $279.71 million. The enterprise value is $344.96 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 98.84 million shares outstanding. The number of shares has increased by 23.11% in one year.
| Current Share Class | 98.84M |
| Shares Outstanding | 98.84M |
| Shares Change (YoY) | +23.11% |
| Shares Change (QoQ) | +4.09% |
| Owned by Insiders (%) | 28.96% |
| Owned by Institutions (%) | 41.06% |
| Float | 64.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | 0.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59
| Current Ratio | 1.59 |
| Quick Ratio | 1.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -13.37% |
| Return on Invested Capital (ROIC) | -61.08% |
| Return on Capital Employed (ROCE) | -38.51% |
| Weighted Average Cost of Capital (WACC) | 6.28% |
| Revenue Per Employee | $784,289 |
| Profits Per Employee | -$78,479 |
| Employee Count | 641 |
| Asset Turnover | 2.98 |
| Inventory Turnover | 31.68 |
Taxes
| Income Tax | -131,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.25% in the last 52 weeks. The beta is 0.21, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +148.25% |
| 50-Day Moving Average | 2.91 |
| 200-Day Moving Average | 3.34 |
| Relative Strength Index (RSI) | 43.80 |
| Average Volume (20 Days) | 2,562,036 |
Short Selling Information
The latest short interest is 8.98 million, so 9.09% of the outstanding shares have been sold short.
| Short Interest | 8.98M |
| Short Previous Month | 9.08M |
| Short % of Shares Out | 9.09% |
| Short % of Float | 13.87% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, TOI had revenue of $502.73 million and -$50.31 million in losses. Loss per share was -$0.54.
| Revenue | 502.73M |
| Gross Profit | 76.44M |
| Operating Income | -36.08M |
| Pretax Income | -60.74M |
| Net Income | -50.31M |
| EBITDA | -29.14M |
| EBIT | -36.08M |
| Loss Per Share | -$0.54 |
Full Income StatementBalance Sheet
The company has $33.57 million in cash and $103.75 million in debt, with a net cash position of -$70.19 million or -$0.71 per share.
| Cash & Cash Equivalents | 33.57M |
| Total Debt | 103.75M |
| Net Cash | -70.19M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | -15.72M |
| Book Value Per Share | -0.16 |
| Working Capital | 41.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.59 million and capital expenditures -$3.20 million, giving a free cash flow of -$27.79 million.
| Operating Cash Flow | -24.59M |
| Capital Expenditures | -3.20M |
| Depreciation & Amortization | 6.94M |
| Net Borrowing | -21.03M |
| Free Cash Flow | -27.79M |
| FCF Per Share | -$0.28 |
Full Cash Flow StatementMargins
Gross margin is 15.20%, with operating and profit margins of -7.18% and -12.06%.
| Gross Margin | 15.20% |
| Operating Margin | -7.18% |
| Pretax Margin | -12.08% |
| Profit Margin | -12.06% |
| EBITDA Margin | -5.80% |
| EBIT Margin | -7.18% |
| FCF Margin | n/a |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.11% |
| Shareholder Yield | -23.11% |
| Earnings Yield | -18.31% |
| FCF Yield | -10.11% |
Analyst Forecast
The average price target for TOI is $6.67, which is 135.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.67 |
| Price Target Difference | 135.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of 1.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.13 |
| Piotroski F-Score | 4 |
